Cytotoxic activities of silver nanoparticles and silver ions in parent and tamoxifen-resistant T47d human breast cancer cells and their combination effects with tamoxifen against resistant cells

Avicenna Journal of Medical Biotechnology

Volumn 2, Issue 4, 2010, Pages 187-196

  Ostad, Seyed Naser ^a   Dehnad, Shahrzad ^b,c   Nazari, Zeinab Esmail ^b   Fini, Shohreh Tavajohi ^a   Mokhtari, Narges ^b   Shakibaie, Mojtaba ^b   Shahverdi, Ahmad Reza ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

Breast neoplasms; Chemotherapy; Cytotoxicity; Nanoparticles; Tamoxifen

Indexed keywords

SILVER; SILVER NANOPARTICLE; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER CELL; CELL PROLIFERATION; CELL TYPE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOTOXICITY; CYTOTOXICITY TEST; EXPERIMENTAL STUDY; HUMAN; HUMAN CELL; IC 50;

EID: 79251549810     PISSN: 20082835     EISSN: 20084625     Source Type: Journal    
DOI: None     Document Type: Article

References (57)

1. Parak WJ, Manna L, Simmel FC, Gerion D, Alivisatos P. Quantum dots. In: Schmid G (eds). Nanoparticles: from theory to application. Weinheim: Wiley-VCH; 2004,4-49.
2. Mohanraj VJ, Chen Y. Nanoparticles; a review. Trop J Pharm Res 2006;5(1):561-573.
3. Mohanpuria P, Rana NK, Yadav SK. Biosynthesis of nanoparticles: technological concepts and future applications. J Nanopart Res 2008;10(3):507-517.
4. Henglein A. Physicochemical properties of small metal particles in solution: "microelectrode" reactions, chemisorption, composite metal particles, and the atom-to-metal transition. J Phys Chem 1993;97(21):5457-5471.
5. Panacek A, Kvitek L, Prucek-Kolar RM, Vecerova R, Pizurova N, Sharma VK, et al. Silver colloid nanoparticles: synthesis, characterization, and their antibacterial activity. J Phys Chem B 2006;110 (33):16248-16253.
6. Dubey M, Bhadauria S, Kushwah BS. Green synthesis of nanosilver particles from extract of eucalyptus hybrida (saeda) leaf. Dig J Nanomater Bios 2009;4(3):537-543.
7. Goldberg M, Langer R, Jia X. Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Edn 2007;18(3):241-268.
8. Stefania P, Oumarou S, Philippe P, L'Hocine Y. Applications of carbon nanotubes-based biomaterials in biomedical nanotechnology. J Nanosci Nanotechnol 2006;6(7):1883-1904.
9. Law M, Goldberger J, Yang P. Semiconductor nanowires and nanotubes. Annu Rev Mater Res 2004;34:83-122.
10. Rhyner MN, Smith AM, Gao X, Mao H, Yang L, Nie S. Quantum dots and multifunctional nanoparticles: new contrast agents for tumor imaging. Nanomedicine 2006;1(2):209-217.
11. Sinha V, Trehan A. Biodegradable microspheres as protein delivery. J Control Release 2003;90(3): 261-280.
12. Nam JA, Thaxton CS, Mirkin CA. Nanoparticlebased bio-bar codes for the ultrasensitive detection of proteins. Science 2003;301(5641):1884-1886.
13. Sondi I, Sondi B. Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for gram-negative bacteria. J Colloid Interf Sci 2004;275(1):177-182.
14. Gottesman MM, Fojo T, Bates SE. Multidrug resistance in cancer: role of ATP-dependent transporters. Nat Rev Cancer 2002;2:48-58.
15. Harris AL, Hochhauser D. Mechanisms of multidrug resistance in cancer treatment. Acta Oncol 1992;31:205-213.
16. Di Niclantonio F, Mercer SJ, Knight LA, Gabriel FG, Whitehouse PA, Sharma S, et al. Cancer cell adaptation to chemotherapy, BMC Cancer 2005; 5:78.
17. Ganasia-Leymarie V, Bischoff P, Bergerat J P, Holl V. Signal transduction pathways of taxanesinduced apoptosis. Curr Med Chem Anti-Cancer Agents 2003;3(4):291-306.
18. Zhang B, Faller DV, Wang S. HIC1 regulates tumor cell responses to endocrine therapies. Mol Endocrinol 2009;23(12):2075-2085.
19. Habashy HO, Powe DG, Staka CM, Rakha EA, Ball G, Green AR, et al. Transferrin receptor (CD71) is a marker of poor prognosis in breast cancer and can predict response to tamoxifen. Breast Cancer Res Treat 2010;119(2):283-293.
20. Giordano C, Cui Y, Barone I, Ando S, Mancini MA, Berno V, et al. Growth factor-induced resistance to tamoxifen is associated with a mutation of estrogen receptor alpha and its phosphorylation at serine 305. Breast Cancer Res Treat 2010;119(1): 71-85.
21. Gunjan G, Duy H, Annelise N T. Combinational treatment of gap junctional activator and tamoxifen in breast cancer cells. Anticancer Drugs 2010;21 (1):77-88.
22. Yezhelyev AV, Gao X, Xing Y, Al-Hajj A, Nie S, O'Regan R M. Emerging use of nanoparticles in diagnosis and treatment of breast cancer. Lancet Oncol 2006;7(8):657-667.
23. Shenoy DB, Amiji MM. Poly(ethylene oxide)- modified poly(-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm 2005;293(1-2):261-270.
24. Prabhu N, Raj D T, Gowrik Y, Siddiqua A, Innocent JP. Synthesis of silver photo nanoparticles and their antibacterial efficacy. Dig J Nanomater Bios 2010;5:185-189.
25. Kim JS, Kuk E, Yu KN, Kim J, Park SJ, Lee HJ, et al. Antimicrobial effects of silver nanoparticles. Nanomed: Nanotechnol Biol Med 2007;3(1):95-101.
26. Raja ASM, Thailagavathi G, Kannaian T. Synthesis of spray dried polyvinyl pyrrolidone coated silver nanopowder and its application on wool and cotton for microbial resistance. Indian J Fiber & Textile Res 2010;35(1):59-64.
27. Sharma VK, Yngard RA, Lin Y. Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci 2009;145(1-2): 83-96.
28. Hussain SM, Hess KL, Gearhart JM, Geiss KT, Schlager JJ. In vitro toxicity of nanoparticles in BRL 3A rat liver cells. Toxicol In vitro 2005;19 (7):975-983.
29. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri J B, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005;16(10):23-46.
30. Schrand AM, Braydich-Stolle LK, Schlager JJ, Dai L, Hussain SM. Can silver nanoparticles be useful as potential biological labels? Nanotechnology 2008;19(23): 235104.
31. Braydich-Stolle LK, Hussain SM, Schlager JJ, Hofmann MC. In vitro cytotoxicity of nanoparticles in mammalian germline stem cells. Toxicol Sci 2005;88(2):412-419.
32. Poon VKM, Burd A. In vitro cytotoxicity of silver: implication for clinical wound care. Burns 2004; 30(2):140-147.
33. Wataha JC, Lockwood PE, Schedle A. Effect of silver, copper, mercury and nickel on cellular proliferation during extended, low-dose exposures. J Biomed Mater Res 2000;52(2):360-364.
34. Panyala NR, Pena-Mendez EM, Havel J. Silver or silver nanoparticles: a hazardous threat to the environment and human health? J App Biomed 2008;6:117-129.
35. Liu Z W, Ren G G, Zhang T, Yang Z. Action potential changes associated with the inhibitory effects on voltage-gated sodium current of hippocampal CA1 neurons by silver nanoparticles. Toxicology 2009;264(3):179-184.
36. Raveendran P, Fu J, Wallen SL. A simple and''green'' method for the synthesis of Au, Ag, and Au-Ag alloy nanoparticles. Green Chem 2006;8: 34-38.
37. Emami-Forushania A, Azizi E, Zeinali S, Ostad SN. Cross-resistance to vincristin and etoposide in a sub line of the human breast cancer T47D cells selected for adriamycin-resistance. Iranian J Pharm Res 2004;3(2):103-107.
38. Freshney R I. Culture of Animal Cells; a Manual of Basic Techniques. 2nd ed. New Jersey: Wiley- VCH Publications; 2000.
39. Sastry M, Mayya K S, Bandyopadhyay K. pH Dependent changes in the optical properties of carboxylic acid derivatized silver colloidal particles. Colloids Surf A: Physicochem Eng Asp 1997;127(1-3):221-228.
40. Magudapathy P, Gangopadhyay P, Panigrahi BK, Nair KGM, Dhara S. Electrical transport studies of Ag nanoclusters embedded in glass matrix. Physics B 2001;299(1-2):142-146.
41. Okamoto I, Iwamoto K, Watanabe Y, Miyake Y, Ono A. Metal-ion selectivity of chemically modified uracil pairs in DNA duplexes. Chem Int Ed 2009;48(9):1648-1651.
42. Rogers JV, Parkinson CV, Choi YW, Speshock JL, Hussain SM. A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale Res Lett 2008;3(4):129-133.
43. Ahamed M, Karns M, Goodson M, Rowe J, Hussain SM, Schlager JJ, et al. DNA damage response to different surface chemistry of silver nanoparticles in mammalian cells. Toxicol Appl Pharm 2008;233(3):404-410.
44. Rahman F, Wang J, Patterson TA, Saini UT, Robinson B, Newport GD, et al. Expression of genes related to oxidative stress in the mouse brain after exposure to silver-25 nanoparticles. Toxicol Lett 2009;187(1):15-21.
45. Gopinath P, Gogoi SK, Chattopadhayay A, Gosh SS. Implications of silver nanoparticle induced cell apoptosis for in vitro gene therapy. J Nanotechnology 2008;19(7):075104.
46. Zolghadri S, Sabouri AA, Golestani A, Divsalar A, Rezaei-Zarchi S, Moosavi-Movahedi AA. Interaction between silver nanoparticle and bovine hemoglobin at different temperatures. J Nanopart Res 2009;11(7):1751-1758.
47. Morones JR, Elechiguerra JL, Camacho A, Holt K, Kouri JB, Ramirez JT, et al. The bactericidal effect of silver nanoparticles. Nanotechnology 2005;16 (10):2346-2353.
48. Ilker I, Yesilel OZ, Günay G, Büyükgüngör O. Dinuclear and polynuclear silver (I) saccharinate complexes with 1,3-diaminopropane and Nmethylethylenediamine constructed from Ag.C interactions. J Organomet Chem 2009;694(26): 4178-4184.
49. Jin CM, Chen ZF, Mei HF, Shi XK. Ag (I) coordination polymers with flexible bis-imidazole ligands: 2D interwoven structure and wavy layer network based on silver-silver interactions. J Mol Struct 2009;921(1-3):58-62.
50. Shulka J, Pitre KS. Role of bio-metal Fe (III) in anticancer behavior of tamoxifen. Indian J Exp Biol 1999;37(5):429-433.
51. Galanzha EI, Shashkov EV, Kelly T, Kim J, Yang L, Zharov VP. In vivo magnetic enrichment and multiplex photoacoustic detection of circulating tumor cells. Nat Nanotechnol 2009;4:855-860.
52. Agasti SS, Chompoosor A, You C, Ghosh P, Kim CK, Rotello VM. Photoregulated release of caged anticancer drugs from gold nanoparticles. J Am Chem Soc 2009;131(16):5728-5729.
53. Lok C, Ho C, Chen R, He Q, Yu WY, Sun H, et al. Silver nanoparticles: partial oxidation and antibacterial activities. J Biol Inorg Chem 2007;12(4): 527-534.
54. Gelperina S, Kisich K, Iseman MD, Heifets L. The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis. Am J Res Crit Care 2005;172:1487-1490.
55. Napier ME, DeSimone JM. Nanoparticle drug delivery platform. Polym Rev 2007;47(3):321-327.
56. Williams P S, Carpino F, Zborowski M. Magnetic nanoparticle drug carriers and their study by quadrupole magnetic field-flow fractionation. Mol Pharmaceut 2009;6(5):1290-1306.
57. Karlsson HL, Cronholm P, Gustafsson J, Möller L. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 2008;21(9): 1726-1732.